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ABSTRACT:  The undertreatment of pain is a major public health issue worldwide.  According 
to the World Health Organization (WHO), the gold standard for the treatment of severe, chronic 
pain is morphine;
i
 however, access to this treatment in the majority of developing countries is 
difficult to impossible for a number of reasons.  Well-documented and universal barriers include 
supply and delivery systems that are ill-equipped to adequately manage opioid medication 
accountability, regulatory barriers and national policies that do not recognize pain as important, 
and lack of health care professional education and awareness, as well as fear of regulatory 
retribution.  Current research has shown that only 19% of the world demonstrates acceptable 
environments for hospice, just one illustration of the dire circumstances for people living and 
dying with pain.  For more than a decade, researchers have worked to define barriers to accessing 
pain care and determine ways to overcome them.  Work is underway around the world to help 
thoughtfully and systematically overcome these barriers.  More recently, pain care, particularly 
for severe pain at the end of life, has been framed as a human right and moral imperative through 
various professional organization declarations, position statements and published research.   This 
singular message has the power to help overcome the barriers stated above.  However, the 
inclusion of the voice of the humans actually suffering from pain as a transformative force has 
been largely overlooked as an essential part of the advocacy process.  This research explores the 
role of the patient advocate in helping to improve pain care, and identifies a crossroads of current 
efforts where efforts to raise awareness among people with pain, providers, policy makers and 
the general public can and have made a difference.  It also explores the possibility of an 
international information exchange explicitly for the use of pain advocates to share their victories 
and help determine best practices that can be adapted in countries with similar environmental 
conditions.   
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The undertreatment of pain is a public health crisis on a global level.  In the United States, 
information, advocacy and empowerment have been the focus of consumers with pain as a way 
to improve pain care, led in part by consumer advocacy organizations such as the American Pain 
Foundation (APF), as well as the American Chronic 
Pain Association, American Cancer Society and 
LIVESTRONG.  On interpersonal and community 
levels, social networks and systems have been 
galvanized to affect policy-level changes, evidenced by 
the work of the APF Action Network, as just one 
example.  On a global level, however, efforts to improve 
access to pain care have focused on overcoming barriers with policy changes and improved 
health care education about pain management.  Is there evidence of consumer engagement and 
advocacy as an effective strategy for improving access to pain care around the world? 
 
Advocacy, as defined by the Global Health Council, is a “set of targeted actions directed at 
decision makers in support of a specific policy issue.”ii  Advocates certainly include passionate 
health care professionals: much of the global work in improving access to pain care thus far can 
be attributed to their efforts.  However, advocacy can, and arguably should, include people who 
are experiencing pain first-hand and their loved ones.  Their stories have the power to overcome 
numerous barriers that people with pain around the world face every day.  It is important to note 
that advocacy as discussed in this paper refers to activities as defined above; one international 
pain organization shared that their health care professional members were not interested in 
The right to be free from torture, cruel, 
inhuman, and degrading treatment or 
punishment is a fundamental human right 
that is recognized in numerous 
international human rights instruments.  
The palliative care and pain treatment gap 
is an international human rights crisis that 
needs to be addressed urgently both at the 
international and national level. 
– Human Rights Watch, 20111 
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“advocacy,” a term that refers to more of a legal advocate in some parts of Europe, however  
they expressed interest in conducting policy, communication and awareness activities. 
 
It is important to recognize that pain patient advocacy 
efforts, particularly those with end-of-life pain, are 
universally challenged because people, and often their 
families, are in a state of crisis and do not have the strength or emotional resources to call upon 
to engage in a process of speaking up for change.  However, as incremental gains are made 
throughout the world in accessing pain care, there will be a growing number of people who are, 
for the first time, able to participate in advocacy efforts.  Families who have had either a positive 
experience with hospice or negative experience without it may want to help others.  Therefore, 
the idea is not that people who are living in agony will ever have the strength to rise from their 
deathbeds to demand change; part of why pain care is globally neglected is because we know 
that they can’t.  Instead, it is to encourage those whose lives have been changed with appropriate 
pain care to share their story, and to encourage pivotal decision makers and influencers to 
recognize and validate the personal pain story as real and important. 
 
The role of patient advocates is briefly mentioned at the end of the Open Society Foundation, 
International Palliative Care Program’s 2010 report, “Easing the Pain: Success and Challenges in 
International Palliative care,” – one of the only published references to this group of people and 
the premise for this research.  The report concludes with the following recommendation:  
 Encourage a strong civil society voice, especially among patient advocates. Educating the 
public about the right to pain relief and palliative care is essential.  Patients and patient 
Illness and death are facts of life, but 
suffering need not be.  
–Open Society Foundation1 
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support groups for the elderly, the disabled, and children—along with family members and 
activists— need to demand relief from pain and access to effective treatments to improve 
quality of life. Such groups need to put palliative care and pain relief on their advocacy 
agendas and work to reform government policies that prevent them from receiving quality 
care at the most vulnerable time of their lives. They need to monitor their governments’ 
health budgets to be assured that appropriated funds are spent for accessible services.
iii
  
 
A World in Pain  
Although the World Health Organization (WHO) considers palliative care an integral component 
of cancer care and has urged countries to improve its availability, too often palliative care 
continues to receive low priority from health policy makers and health care professionals, and 
almost no funding. This is despite the fact that experts estimate that 60 percent of those who die 
each year in the developing world—a staggering 33 million people—need palliative care. In 
part, this is because most cancer patients in developing countries are diagnosed when they have 
advanced disease and cannot be cured, so the only treatment option is palliative care.
iv
 
 
This number does not account for the myriad of acute and chronic conditions that are not 
terminal.  Low-back pain, fibromyalgia, arthritis, neuropathies and other non-communicable 
diseases are not addressed with the world’s more pressing health concerns, such as the spread of 
infectious HIV/AIDS or tuberculosis, and emerging public health threats of obesity and 
population control.  This also does not account for chronic pain associated headache and 
migraine, of which WHO recently stated were among the most prevalent disorders experienced 
by mankind.
v
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Chronic pain conditions have been shown to be “life-shortening” as opposed to “life-
threatening.”  From a public health perspective, large-scale surveys in many countries have 
established that chronic non-cancer pain ranks as the third most costly health care problem after 
cancer and cardiovascular disease and that the problem is costlier in developing countries. Poorly 
relieved pain also leads to accelerated mortality.
vi
   
 
The United Nations has declared that non-communicable diseases represent a new frontier in the 
fight to improve global health. Worldwide, the increase in such diseases means that they are now 
responsible for more deaths than all other causes combined. Commonly known as chronic or 
lifestyle-related diseases, the main non-communicable diseases are cardiovascular diseases, 
diabetes, cancers and chronic respiratory diseases. While the international community has 
focused on communicable diseases such as HIV/AIDS, malaria and tuberculosis, the four main 
non-communicable diseases have emerged relatively unnoticed in the developing world and are 
now becoming a global epidemic.
vii
  Communicable or not, pain is a hallmark of HIV/AIDS, 
cancer, diabetic neuropathy, arthritis, headache and countless other diseases, but has not received 
the attention that it deserves. 
 
WHO estimates that 5 billion people live in countries with low or no access to controlled 
medicines and have no or insufficient access to treatment for moderate to severe pain. In these 
countries, each year tens of millions of patients are suffering without adequate treatment:
 viii
 
 1 million end-stage HIV/AIDS patients 
 5.5 million terminal cancer patients 
 0.8 million patients suffering injuries, caused by accidents and violence 
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 Patients with chronic illnesses 
 Patients recovering from surgery 
 Women in labor (110 million births each year) 
 Pediatric patients 
 
The sheer numbers of people with pain around the world are difficult to imagine; this number 
can be multiplied many times over when the number of people affected by pain, including 
spouses, siblings, parents, children, loved ones and co-workers are factored in.   
 
Global Palliative Care 
Pain can be experienced as mild, 
moderate or severe.  It can be acute or 
chronic, lasting months or years, or 
until the end of life.  A myriad of 
options have been shown to effectively 
relieve pain in different scenarios, 
including pharmacotherapy, physical 
rehabilitation, psychosocial support, 
acupuncture, herbal remedies, injection 
and infusion therapies, and surgery.
ix
  
In order to even begin to address the 
undertreatment of pain, it is necessary 
to first look at palliative/end-of-life 
WHO's pain ladder 
WHO has developed a three-step "ladder" for 
cancer pain relief. 
If pain occurs, there should be prompt oral 
administration of drugs in the following order: 
non-opioids (aspirin and paracetamol); then, as 
necessary, mild opioids (codeine); then strong 
opioids such as morphine, until the patient is 
free of pain. To calm fears and anxiety, 
additional drugs – “adjuvants” – should be 
used. To maintain freedom from pain, drugs 
should be given “by the clock”, that is every 3-
6 hours, rather than “on demand” This three-
step approach of administering the right drug in 
the right dose at the right time is inexpensive 
and 80-90 percent effective. Surgical 
intervention on appropriate nerves may provide 
further pain relief if drugs are not wholly 
effective. 
SOURCE: World Health Organization 
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pain care in the most severe circumstances.  Simply put, this means access to opioid pain 
medication.  The WHO Pain Relief Ladder recommends the administration of different types of 
analgesics based on the severity of the pain and relies on the permanent availability of opioid 
pain medication as the gold standard for severe pain. 
 
Globally, only about 5-10 percent of patients suffering from moderate and severe pain from 
cancer, end stage HIV/AIDS and many other causes may be receiving adequate treatment, as 
defined by WHO (see sidebar).  While opioid consumption worldwide continues to rise, 
disparities among countries have remained the same or increased.  Africa accounts for less than 1 
percent of global morphine consumption.
x
 
 
The United Nations Single Convention on Narcotic Drugs 
The UN Single Convention on Narcotic Drugs, first published in 1961, then revised in 1972, set 
the wheels in motion for restricted access to morphine around the world in an effort to address 
the growing scourge of drug abuse.  The convention established the International Narcotic 
Control Board (INCB) to monitor global movement of narcotic drugs, defined schedules of 
medication to control, and developed reporting systems to monitor usage of controlled 
substances.  However, this effort to help reduce drug abuse and addiction was not intended to 
come at the expense of pain care.  The preamble of this convention states: 
Recognizing that the medical use of narcotic drugs continues to be indispensable for the 
relief of pain and suffering and that adequate provision must be made to ensure the 
availability of narcotic drugs for such purpose…xi 
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WHO and the INCB have repeatedly drawn attention to the enormous unmet need for pain 
treatment and called for countries to meet this need through low-cost palliative care services. 
According to research from the U.S.-based Pain and Policy Studies Group (PPSG), INCB has 
acknowledged that opioids are not sufficiently available for medical purposes.  WHO and a 
number of national governments have recognized this reality: the president of the INCB has 
stated that access to morphine and other strong pain medicines is “virtually non-existent in over 
150 countries.”xii 
 
There are many reasons why these medications are inadequately available, including:  
(1) a country’s economic and social development (e.g., life expectancy, level of education, and 
economic factors); 
(2) the low priority for pain management in a country’s healthcare system; 
(3) high prevalence of concerns about the development of iatrogenic dependence syndrome (an 
international term synonymous with “substance dependence” in the U.S.); 
(4) problems in procurement, manufacture and distribution of opioids, and; 
(5) unduly-restrictive national drug control policies.
xiii
 
 
Guidance documents from international bodies such as WHO are important tools to help clarify 
the intent of global control of opioid pain medication and establish ways to improve 
accessibility.  In March 2011, WHO published updated guidelines, titled “Ensuring Balance in 
National Policies on Controlled Substances: Guidance for Availability and Accessibility of 
Controlled Medicines,” which have been endorsed by the INCB. xiv These guidelines address:  
 national drug policy; 
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 assigning administrative responsibility, availability and accessibility of medications 
based on discrimination and setting; 
 education of health care professionals and authority to prescribe controlled substances for 
pain, 
 estimates and reporting; and, 
 procurement and national purview to control medicines not controlled by the INCB.  
 
Are the Barriers to Effective Pain Care Universal?   
There are many reasons for the enormity of the gap between pain treatment needs and what is 
delivered, but chief among them is what Human Rights Watch describes as “a shocking 
willingness by many governments around the world to passively stand by as people suffer.”xv  
 
Consider: 
 Few governments have put in place effective supply and distribution systems for morphine  
 Many countries have no pain management and palliative care policies or guidelines for 
practitioners 
 Excessively strict drug control regulations that 
unnecessarily impede access to morphine or establish 
excessive penalties for mishandling it are in place 
 Lack of mandatory health care professional instruction 
on pain management and palliative care, and  
 Insufficient efforts to ensure morphine is affordable.  
 
Unlike so many global health 
problems, pain treatment is not 
about money or a lack of drugs, 
since morphine costs pennies per 
dose. The culprits are bureaucratic 
hurdles and the chilling effect of the 
global war on drugs. 
– The UBC PAIN Project1 
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Fears that medical morphine may be diverted for illicit purposes are a key factor blocking 
improved access to pain treatment.  While states must take steps to prevent diversion, they must 
do so in a way that does not unnecessarily impede access to essential medications. INCB has 
stated that such diversion is relatively rare.
xvi
   
 
In their 2009 report “Please Don’t Make Us Suffer Any More: Access to Pain Care as a Human 
Right,” Human Rights Watch described the following well-documented and universal barriers to 
access to pain care: 
 SUPPLY: (Failure to ensure a functioning and effective supply system) 
 POLICY: (Failure to enact palliative care and pain treatment policies; excessively 
restrictive drug control regulations or enforcement practices, fears of legal sanction 
among health care providers) 
 EDUCATION: (Lack of training for health care workers)xvii  
 
An outgrowth of their earlier work, in June of 2011 Human Rights Watch published the results a 
survey that mapped barriers to pain care access based on opioid consumption. Their findings 
confirmed these widely-researched barriers and provided specific, new information that helps to 
better inform the scope and severity of these barriers to pain care on a global level.  This report 
relies on interviews with country representatives; interestingly, not even established experts can 
agree upon or cite information that correlates with each other about barriers.  The report is a 
starting point for comparison with other countries and further exploration about individual 
country infrastructure, as it looks at a single, albeit critical measure of a country’s pain 
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management landscape.  An appreciation of these barriers can help inform patient advocates and 
identify opportunities where they can effect positive change. 
 
Not surprisingly, Human Rights Watch uncovered an enormous 
unmet need for pain treatment around the world. Fourteen 
countries reported no consumption of opioid pain medicines 
between 2006 and 2008, meaning that there are no medicines to 
treat moderate to severe pain available through legitimate 
medical channels in those countries. In a further eight countries 
that do not report opioid consumption to the International 
Narcotics Control Board the situation is likely similar, as 
countries that participate in the international drug control regime 
undertake not to export opioids to these countries.  Thirteen other 
countries do not consume enough opioids to treat even one 
percent of their terminal cancer and HIV/AIDS patients.
xviii
 
 
The combined suffering due to lack of opioid pain medicines 
worldwide is staggering. Human Rights Watch calculations 
estimate that more than 3.5 million terminal cancer and 
HIV/AIDS patients alone die each year without access to 
adequate pain treatment. This includes at least: 
 1.7 million terminal cancer and HIV/AIDS patients in Asia,  
 1.2 million in sub-Saharan Africa,  
No Consumption of Opioids 
 Antigua and Barbuda  
 Bolivia 
 Cameroon  
 Comoros 
 Djibouti 
 Gambia 
 Guinea 
 Guinea-Bissau 
 Kiribati 
 Honduras 
 Swaziland 
 Solomon Islands 
 Tanzania  
 Tuvalu 
 
Do Not Report Opioid 
Consumption 
 Afghanistan 
 Belize 
 Equatorial Guinea 
 Fiji 
 Liberia 
 Niue 
 Somalia 
 Timor-Leste 
 
Do Not Consume Enough to 
Treat 1% of their Terminal 
HIV/AIDS Patients 
 Burkina Faso 
 Burundi 
 Cambodia 
 Central African 
Republic 
 Chad 
 Cote d’Ivoire 
 Ethiopia 
 Haiti 
 Malawi 
 Mali 
 Niger 
 Nigeria 
 Rwanda 
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 480,000 in Europe,  
 180,000 in the Middle East and North Africa, and  
 100,000 in the Americas.  
 
It must be emphasized that these are very conservative estimates, which assume that all opioids 
are used to treat this patient group. This is why it is lower than WHO’s estimate that each year 
5.5 million terminal cancer patients and 1 million patients in the last phases of HIV/AIDS suffer 
without pain treatment.
xix
 
 
Supply & Delivery Systems 
Opioid analgesics are controlled medicines. As such, their manufacture, distribution and 
prescription are strictly regulated; these medications cannot be traded freely on the market. 
In countries where most people have access to the medicines they need most of the time, 
consumption of opioids is much higher than that which is necessary to treat terminal cancer and 
HIV/AIDS patients.  Countries who can treat only those patients still have a very long way to go 
to ensure all patients in need can access essential pain medicines.
 xx
 
 
Presumably, an environment that is accepting of compassion at the end of life and has built an 
infrastructure to support that environment is ideal. Unfortunately, this is not the case for 81 
percent of the world, according to research from the Worldwide Palliative Care Alliance 
(WPCA), who conducted a mapping exercise to determine the global palliative care environment 
based on capacity building efforts and provision of care.
xxi
  The countries are categorized based 
on the following criteria:  
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1) No known hospice-palliative care activity;  
2) Capacity building activity;  
3a-b) Isolated/Generalized palliative care provision;  
4a-b) Preliminary/Advanced stages of mainstream integration.   
 
TABLE 1: Gross changes in the number of countries in each category from 2006-2011 
Group 2006 2011 Change=n Change=% 
Group 1 78 (33%) 75 (32%) -3 -1% 
Group 2 41 (18%) 23 (10%) -18 -8% 
Group 3 80 (34%) 91 (39%) +11 +5% 
Group 4 35 (15%) 45 (19%) +10 +4% 
 
The detailed analysis allows researchers to examine the few bright spots, such as improvements 
in African countries Malawi, Tanzania, Zambia, and Zimbabwe.  Hospice bed availability, 
medication availability and the establishment of a national association of palliative care also 
reflected positively on several countries in Central and Eastern Europe.  There is no doubt that 
these small gains on paper are the result of extraordinary and painstaking efforts to change 
systems at every level.  In fact, the countries that are experiencing environments of change may 
be the most open to the inclusion of voices of people with pain and their families in helping to 
shape policy and curriculum as a part of the formative stage.  This could conceivably represent 
nearly half (49%) of the world.
xxii
 
 
National Pain & Palliative Care Policies 
WHO has stressed the importance of comprehensive strategies to improve access to palliative 
care.
xxiii
  Human Rights Watch sought information about the availability of national palliative 
care policies; whether palliative care was addressed in national cancer and HIV control policies 
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or plans; and whether oral and injectable morphine were included on national essential medicines 
lists. Their research uncovered the following: 
 
National Palliative Care Policies: Of the 40 countries surveyed, 29 did not have a 
national palliative care policy. Those that did include: Argentina, Brazil, Indonesia, 
France, the Philippines, Poland, South Korea, Turkey, Uganda, the UK, and Vietnam.
xxiv
 
Although survey respondents were not directly asked about implementation, in two of 
these countries, Argentina and Brazil, the respondents told Human Rights Watch that the 
governments were not actually implementing the palliative care policies. In Indonesia, 
survey respondents said that policies were only partially implemented.
 xxv
 
 
National Cancer Control Policies and Plans: National cancer control policies and plans 
of 24 of the 40 countries surveyed make reference to pain management or palliative care. 
Eight countries do not have a national cancer control policy or plan at all. In some 
countries, like India, the reference to palliative care is essentially rhetorical as it is not 
backed up by an action plan, targets, or budget allocation. It is not clear in how many of 
the other countries surveyed that is the case.
 xxvi
 
 
National HIV/AIDS Control Policies and Plans: In 23 countries surveyed, national 
AIDS control policies did not make reference to palliative care, including three high 
burden countries—Cameroon, Ethiopia, and Kenya. AIDS control policies in 11 
countries surveyed made reference to palliative care, including a number of high burden 
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countries like South Africa, Tanzania, Nigeria, and Uganda. Four of the countries 
surveyed do not have a national AIDS control policy at all.
 xxvii
 
 
There is clearly much room for improvement in the development of national policies to create 
environments where pain and palliative care are recognized as critical components to overall 
health care.   
 
Health Care Professional Education 
Inadequate training in pain is strongly implicated in insufficient treatment.  An expert panel 
convened by the Mayday Fund reported: . . . current systems of care do not adequately train or 
support internists, family physicians and pediatricians, [who are] the other health care providers 
who provide primary care in meeting the challenge of treating pain as a chronic illness. Primary 
care providers often receive little training in the assessment and treatment of complex chronic 
pain conditions. They tend to work under conditions that permit little time with each individual 
and few options for specialist referrals.
xxviii
  
 
The European countries surveyed by Human Rights Watch have the most extensive availability 
of training in pain management of any region. In France, Poland, and the United Kingdom, 
training in palliative care is compulsory for all undergraduate medical students. In 2009 
Germany introduced legislation that will make training in palliative care compulsory for all 
undergraduate medical students by 2014. In all other countries surveyed, with the exception of 
Russia, palliative care instruction was available in at least some undergraduate medical 
programs.
xxix
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A member survey of the International Association for the Study of Pain (IASP) found that in 
assessing challenges to improving pain management on a national level, lack of pain specialists 
was cited by 100 percent of respondents. Ninety (90) percent of respondents indicated that pain 
specialists represented 5 percent or less of the health care providers in their nation, with 47 
percent of respondents indicating that 5 percent or less of pain specialists were MDs.
xxx
 
 
The importance of health care professional education surrounding pain care can not be 
overstated.  These practitioners, often primary care physicians as opposed to pain specialists or 
oncologists, are on the “front lines” of patient care.  An “uneducated” physician can feel that he 
or she has no tools in their arsenal and develop a callous attitude toward their suffering patients.  
Even the most compassionate providers can also feel that their “hands are tied” when it comes to 
providing relief if they are relying on outdated teachings about pain care, or if there are 
justifiable concerns over regulatory retribution.  
 
Approaching Access to Pain Care as a Human Right 
Currently, WHO recognizes access to essential 
medicines as a human right among the priorities of 
implementation of pharmaceutical policies, and WHO’s 
joint effort with the United Nations Committee on 
Economic, Social and Cultural Rights, the body in 
charge of the surveillance of the International Covenant 
of Economic, Social and Cultural Rights (ICESCR).  
This has resulted in the inclusion of access to essential 
Many people interviewed by 
Human Rights Watch who had 
experienced severe pain in India, 
expressed the exact same sentiment 
as torture survivors: all they 
wanted was for the pain to stop. 
Unable to sign a confession to 
make that happen, several people 
told us that they had wanted to 
commit suicide to end the pain, 
prayed to be taken away, or told 
doctors or relatives that they 
wanted to die.
1
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medicines in the core content of the right to health.  The Committee states that the right to health 
contains a series of interrelated and minimum elements, such as availability, accessibility, 
acceptability and quality of health goods, services and programs. In this framework, medicines 
must be available in sufficient quantity, without discrimination, overcoming physical and 
economical constrictions and respecting medical ethics, provided that they are scientifically and 
medically appropriate.  These four elements are in line with the WHO statement that essential 
medicines are intended to be available within the context of health systems in adequate amounts 
at all times, in the appropriate dosage forms, with assured quality and information, and at a price 
that the individual and the community can afford.
xxxi
 WHO’s Model List of Essential Medicines 
includes morphine in oral tablet, oral solution, and injectable formulations; clearly, this theory 
does not meet practice. 
 
How can positioning access to pain care as a human right support advocacy efforts?  
A special-theme Bulletin of the WHO on Intellectual Property Rights and Public Health states: 
“Approaching access to essential medicines as a right not only opens a subjective dimension that 
refers to individual enforceability of the right to health, but modifies issues such as the 
relationship between access to medicines and intellectual property rights, strengthening the 
patient’s position.  Likewise, it allows a merely ethical valorization to be overcome in favor of 
the analysis of actions adopted in the framework of public health in a context of legal 
enforceability.”  Further, a human rights approach applied to access to essential medicines such 
as morphine have the potential to provide new tools for analysis, action, accountability, and 
alignment of policies and advocacy work.
 xxxii 
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Nearly 20 years ago, Margaret Somerville, a preeminent scholar of medical law, made a case that 
the relief of suffering is a common goal of both medicine and human rights, and that the relief of 
the pain and suffering of terminally ill patients is a human right.
xxxiii
  Subsequently, a number of 
international organizations have built upon that premise to establish access to pain care as a 
fundamental human right over the past decade, including:  
 Standing Committee of the Canadian Senate;  
 The Cape Town Declaration;   
 The European Committee of Ministers;  
 The International Working Group (European School of Oncology);   
 Pope Benedict XVI; and,  
 The Korea Declaration.xxxiv   
 
More recently, the Union for International Cancer Control (UICC) included “Universal 
Availability of Effective Pain Control” in its World Cancer Declaration (2009) and the IASP 
issued the “Declaration of Montreal” in September 2011.  These declarations have been 
collectively useful for the continued establishment and recognition of the human rights case for 
access to pain care, but have also received various levels of commitment from their sponsoring 
organizations toward promotion and awareness of the declarations themselves.  Therefore, while 
declarations can be a useful tool in helping to establish support and galvanizing action, they run 
the risk of serving as empty vessels if not structured as a part of a more comprehensive effort. 
 
Considering this in his research about the premise of pain care as a human right and its 
promotion, Brennan concludes: “Given the enormous unmet needs of patients with life-limiting 
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illnesses in the world, it is not surprising that advocates have promoted the provision of palliative 
care as a human right. Indeed, those statements have emerged in an era where links are being 
generally made between health and human rights. A human right to palliative care may be 
implied from the international right to health care. However, that right should not be seen in 
isolation. If the goal is freedom from unnecessary suffering, then the provision of all possible 
measures to ensure that relief is met must be present including adequate housing, nutrition, 
water, and sanitation. For the progressive fulfillment of a human right to palliative care, much 
will be required: flexible and creative public policy, greater access to opioids for medical 
purposes, tireless advocacy, comprehensive education, professional leadership, and continued 
calls upon individual compassion for this most vulnerable group of people.”xxxv 
 
When viewed against the lens of human rights, governments have an obligation to take measures 
to protect their citizens from inhuman and degrading treatment. Failure of governments to take 
reasonable measures to ensure accessibility of pain treatment, which leaves millions of people to 
suffer needlessly from severe and often prolonged pain, raises questions whether they have 
adequately met this obligation.
xxxvi
 
 
Discussion: Where is the Patient Voice around the World to Improve Pain Care?   
While there are a number of recommendations and efforts to reduce barriers to pain care access 
aimed at health care professionals, the inclusion of a global, regional or national strategy to 
leverage the pain patient and caregiver voice to improve pain care is few and far between.   
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The U.S. Institute of Medicine’s “Relieving Pain in America: A Blueprint for Transforming 
Prevention, Care, Education and Research,” a seminal report released in June 2011, is one of the 
rare cases that mentions the role of patient advocacy as part of a national strategy to help 
improve pain care in the United States.  The report provides the perspective lacking in many of 
the global assessments of pain care: just because access is far better compared to the rest of the 
world, it does not mean that people do not also suffer needlessly in America.  The report states 
that, on the federal level, informing the public about pain has not received sustained priority 
attention from the Centers for Disease Control and Prevention (CDC), the Office of the Surgeon 
General, the Agency for Healthcare Research and Quality (AHRQ), or the National Institutes of 
Health (NIH).
xxxvii
 Interestingly, the report confirms that the barriers to pain care cited by other 
research are the same in the United States, including lack of research, policy and systems 
barriers, and a paucity of health care professional education about pain.
 
 
 
Further, while several key national consumer pain advocacy organizations are included in the 
report, the authors highlight the lack of large-scale, systemic, coordinated and strategic ways that 
have been effective in tackling other public health concerns, such as tobacco control, cancer and 
end-of-life issues.  In these cases, consumer and patient advocacy have led to increased public 
awareness, changes in health behaviors, increased research and policy changes.
xxxviii
 The IOM 
report has shed light on the fractious consumer pain advocacy community in just one country – 
albeit a country with enviable access to pain management compared to other countries.  Still, it 
“The saddest part is…there has been no systematic evaluation of the problem; in some 
pockets like in Kerala or in Uganda, some enterprising pioneers bring in a system that’s 
locally suited.  But they’re in pockets…I’m praying for the day that they’ll be an 
evaluation of the burden of suffering in the developing world and an action plan aimed at 
overcoming it.” – M.R. Rajagopal, UBC PAIN Project1 
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enforces the absolute necessity of uniting with a single message to truly make a difference from 
an advocacy perspective. 
 
Public education is a normal public health activity; indeed, “inform, educate, and empower 
people about public health issues” is one of the Ten Essential Public Health Services that every 
public health agency is expected to provide.  Public education enhances the effects of each of the 
concentric circles of major influence on disease control: policy, community-wide environmental 
control measures, community awareness support and action, work and school support, clinical 
expertise, family involvement, and patient self-management.
xxxix
   
 
Faced with a scarcity of official recommendations to conduct patient advocacy work, a number 
of efforts have recently begun to raise awareness of the undertreatment of pain around the world 
and the power of personal testimony.  Organizations such as the IASP and WPCA have begun 
including the consumer voice, together with core strategies to address well-documented barriers 
discussed above.  However, their primary audiences are health care professionals who treat 
people with pain, including terminally ill patients.  While patients and their caregivers may 
benefit from materials developed for this audience, they are not designed for, nor necessarily 
useful for a general consumer advocate.  And, while individual stories have been effectively 
utilized to raise awareness of inequities in pain care, it has not been driven by a mass effort on 
behalf of patients, caregivers and surviving loved ones.  Patient advocacy efforts are an effective 
way to lead change efforts, but presents an untapped potential for the pain patient community. 
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Regional Drug Availability Workshops and International Pain Policy Fellowships are led by the 
previously-mentioned Pain & Policy Studies Group (PPSG), a WHO Collaborating Center at the 
University of Wisconsin, and funded through the International Palliative Care Initiative of the 
Open Society Foundation. PPSG is the only policy center in the world that works specifically on 
opioid availability. Aside from the workshops and fellowships, PPSG provides updated data, 
documents, and other resources such as the annual consumption rates of morphine in countries 
worldwide.
xl
  Their work is evident in much of the progress that has been made.  Other programs 
such as WHO’s Access to Controlled Medicines Programme (ACME) help create an 
environment of receptivity for consumer advocacy, where public testimony and awareness could 
be viewed as a informative to the process. 
 
Incremental, but meaningful changes are being made to improve pain care in parts of the world.  
These bright spots are highlighted and celebrated as success stories.  Against all odds, Uganda 
has been identified as a beacon of hope in sub-saharan African pain care, as barriers were 
identified and overcome with dizzying speed.  In the last 10 years, Uganda has led the African 
continent in efforts to improve access to palliative care, making significant progress on a number 
of fronts.
xli
 (See case study below) 
 
Case Study: Uganda 
 
The introduction of morphine – described by Dr. Anne Merriman, founder of Hospice Africa and Hospice Africa 
Uganda as “essential component of health care” was a particular challenge in an African country such as Uganda in 
1993. Uganda, which lacks economic resources, has few doctors (1: 19,000 population), and nurses (1:5,000 
population) and where 57% of the population never see a health worker. Traditional healers are the first point of 
contact (1:450 population).
xlii
  However, the universal barriers to pain care faced by people around the world, in 
addition to the particular challenges cited above, have been overcome with common sense, dedication and 
remarkable swiftness.  Government support of improved pain care efforts was crucial.  With the help of the Ministry 
of Health, oral affordable morphine was brought into Uganda in September 1993.
xliii
   
 
In its five-year Strategic Health Plan for 2000-2005, Uganda became the first African country to state that palliative 
care was an essential clinical service for all citizens. Since then, the government has worked to improve the 
availability of narcotic medications. It added liquid morphine to its essential drug list and adopted a new set of 
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Guidelines for Handling of Class A Drugs for health care practitioners, also a first in Africa. The Ministry of Health 
also started importing oral morphine powder and providing oral morphine solution to public health facilities at no 
cost. Since 2000 opioid consumption in morphine equivalence has increased four-fold from less than 0.2 mg per 
person to almost 0.8 mg per person in 2008.
xliv
 
 
Dr. Merriman cites several steps to improving availability of pain care: systems change that allowed for the 
importation of opium powder; policy changes that broadened the base of opioid prescribers to include midwives; 
increased palliative care education among health care providers; practical oral administration that was affordable 
and could be delivered at home; and, protocols for addressing side effects.  Strategic advocacy efforts with 
government officials and health care professionals were helpful in initiating the change, but was not a stand-alone.
xlv
  
This sustained shift in improving access to pain care has led the Open Society Foundation and other international 
organizations to herald Uganda as a “pioneer in palliative care” and a “best practice” for reform efforts. xlvi,xlvii   
 
 
Rigorous efforts by policy makers and health care professionals have made the hope of good 
pain care a reality.  Interventions such as the PPSG action plans have been effective across a 
variety of health systems to improve pain care, but do so without the inclusion of personal 
testimony.  The success of following this model have been described in Columbia, Romania, 
India, Uganda, Italy, and Vietnam, with significant improvements in policies.
xlviii
 In all of these 
countries, though, accessing pain care is still problematic. 
 
These are important and hard-won victories.  Efforts are measurable, but nowhere near the 
volume to achieve a critical mass of change that only a motivated patient population can provide.  
Without concerted efforts to share this information, this movement is in jeopardy of losing 
momentum.  As the pain advocacy community is disjointed in the United States, so, too, is it 
disjointed around the world.  Table 2 outlines initiatives by major international organizations 
who are dedicated to improving pain care and their relevance for consumer advocates.  As noted 
above, these programs and materials might be useful for patients and their families, but are not 
designed with this audience as the end user.  This overview provides a snapshot of how the 
patient community has been overlooked and the opportunity for expanded efforts. 
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TABLE 2. Summary of Current Global Advocacy Efforts to Improve Access to Pain Care 
Organization, 
Leadership 
Effort(s) Description Relevance for Patient Advocacy 
International 
Association for 
the Study of Pain, 
Kathy Kreiter, 
Executive 
Director 
International Pain 
Summit 2010, 
Declaration of 
Montreal, World Year 
Against Pain 
The summit framed the 
issue of access to pain care 
as a human right and 
included profiles of one 
person with pain and one 
caregiver. 
A number of “desirable characteristics” 
were outlined in terms of ways to improve 
access to care, including public awareness. 
The “responsible parties” targeted to 
undertake this task is listed as: Providers 
of health care, patient organizations, and 
health educator programs
xlix
 However, 
consumer advocates are not an audience of 
IASP, nor does the organization intend to 
reach this audience.  Additionally, IASP 
communications center around newsletter 
alerts and in-person meetings as a form of 
information exchange, which is not ideal, 
realistic or intended for broad-scale 
consumer consumption.  However, the 
organization does take responsibility for 
declaring themes for “World Year Against 
Pain” and the creation of materials 
translated into a number of different 
languages that can be utilized by 
consumer advocates to support their 
efforts.  Usage of these materials is not 
tracked. 
 
Worldwide Pain 
Care Alliance 
(WPCA), David 
Praill, WPCA Co-
Chair (Help the 
Hospices, UK); 
Cynthia Goh, 
WPCA Co-Chair 
(Asia Pacific 
Hospice Palliative 
Care Network) 
World Hospice & 
Palliative Care Day 
Each year since 2006, 
World Hospice and 
Palliative Care Day has 
focused on advocacy, 
public awareness, and 
fundraising, with activities 
ranging from radio 
campaigns to conferences 
to concerts. The day 
provides a moment in time 
for both consumer and 
professional pain care 
advocates to conduct 
outreach activities.  A 
growing number of events 
and countries have been 
recorded by WPCA since 
then.  
 
World Hospice & Palliative Care Day is 
facilitated by UK-based “Help the 
Hospices.” WPCA is a global alliance of 
several regional hospice alliances, such as 
the African Palliative Care Association, 
Latin American Palliative Care 
Association and the International 
Association for Hospice & Palliative Care. 
 
A loose online information exchange is 
provided for World Day activities.  While 
a number of events were posted about 
local events, there was very little 
discussion leading up to it, or following.  
 
Global Access to 
Pain Relieve 
Initiative (GAPRI) 
Led by UICC 
President, 
Professor David 
Hill 
Treat the Pain.com is 
GAPRI’s consumer 
website; focus on 
promotion of LIFE 
Before Death 
documentary 
dissemination and 
promotion 
Filmed in 11 countries, the 
documentary film LIFE 
Before Death tells the 
stories of the remarkable 
health professionals 
battling the sweeping 
epidemic of pain. 
GAPRI website offers a real opportunity 
for pain advocates to take action, but does 
not offer any platforms for connection or 
exchange of information. The LIFE 
Before Death film is produced by IASP, 
UICC, the Mayday Fund, the Lien 
Foundation, and the Institute for Palliative 
Medicine at San Diego Hospice 
International Programs. 
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International 
Association of 
Hospice & 
Palliative Care, 
Liliana De Lima, 
Executive 
Director 
 
Faculty development 
programs and 
fellowships 
Works to overcome health 
care professional 
education barriers through 
fellowships and access to 
global database of pain 
research 
 IAHPC is dedicated to improving pain 
care through health care professional 
education.  Consumers are not their 
intended audience. 
Open Society 
Foundation, Kathy 
Foley, MD 
International Palliative 
Care Initiative 
The International 
Palliative Care Initiative 
uses a targeted, multi-
pronged, public health 
approach to advance the 
following priorities: 
reform health policy; make 
available essential 
medicines for pain relief 
and palliative care; 
educate health care 
professionals and policy 
makers; and raise public 
awareness about palliative 
care and the rights of 
patients and families. 
OSF's International Palliative Care 
Initiative, in partnership with the 
American Cancer Society, held a two-day 
seminar in Budapest, Hungary in 2009 that 
brought together teams of cancer and 
palliative care experts from Albania, 
Armenia, Georgia, Hungary, Moldova, 
Romania, Serbia, and Ukraine. At the 
seminar, participants discussed ways of 
improving the ability of patients and civil 
society organizations to advocate for 
effective palliative care and pain relief 
policies. 
Each of the eight country delegations 
delivered presentations on palliative care 
policies and national cancer plans in their 
countries, as well on current efforts of 
patient advocacy groups on these issues. 
The participants discussed advocacy 
strategies to improve existing policies, and 
planned efforts to strengthen collaboration 
and facilitate the exchange of ideas on 
patient advocacy, palliative care, and 
cancer. The delegations also developed 
action plans to engage in-country partners 
on advocacy efforts.  
 
Pain & Policy 
Studies Group, 
Jim Cleary, MD 
WHO Collaborating 
Center for Policy and 
Communications in 
Cancer Care; 
International 
Fellowship Program on 
Opioids 
Facilitate workshops and 
information exchange to 
assist local leaders in 
developing policies based 
on best practices. 
By design, does not include the voice of 
the patient advocate.  
 
 
Recommendations 
Why bother to encourage patient advocacy efforts when the systems are not in place to 
accommodate their demands?  An exchange with Indian palliative care expert and advocate Dr. 
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M.R. Rajagopal elicited the following impassioned sentiment:  “… I react violently against the 
suggestion that patients in pain should not be encouraged to speak up for pain relief lest they get 
frustrated.  How can we sweep something like this under the carpet? We practically torture them 
and then discourage them from speaking up?  But yes, they do not have usually have the strength 
to speak up and hence it would be the relatives or friends who can speak up. I think it has to 
happen first. Or at least side by side with attempts at policy change.  Professional education, 
pain policies and systems all change too slowly, particularly in developing countries. We know 
from experience that the public voice forces administrators, politicians and professionals to 
change.”l   
 
1) Encourage the international pain community to actively 
invite and accept testimony about personal pain experience 
when developing policy, creating public awareness 
campaigns and educating health care professionals.  The active inclusion of the patient 
voice has been largely absent from an international pain advocacy movement.  This is not to 
say that patients and their families have not been featured as a part of advocacy efforts; 
indeed, these stories are truly the most compelling component of the current campaigns such 
as LIFE Before Death and the UBC PAIN Project.  These individual stories have been 
utilized to put a face to the devastation that withholding pain care can bring, and this 
illustration is an important one.  However, there is little evidence that they are actively 
working to improve pain care, or have been asked to be a part of that process. 
 
In a global village, everyone 
is a neighbor.  But who will 
carry the torch for 
knowledge exchange and 
inspire hope? 
– Lien Foundation1 
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Good global public health interventions and programs are developed with input from “local” 
representatives and constituents.  Professional organizations and their leadership must 
consider input from the “residents” of this world of agony to help inform their good 
intentions.  In doing so, not only will the policies be better for it, but it will help patient 
advocates gain a better understanding of leveraging the power of their stories.  It will further 
extend the positive effects of programs like the PPSG fellowships by cultivating advocacy 
for the first waves of patients whose pain has been treated, and their families. 
 
2) Expand the global pain advocacy movement beyond cancer and end-of-life care.  While 
cancer and end-of-life pain care are certainly a critical component to improving access to 
pain care, it must not be limited to those categories.  To quote international pain advocacy 
leaders James Cleary, Paul Hutson and David Joranson: “A global pain relief initiative also 
runs a significant risk if it is limited to cancer pain as it may inadvertently increase disparities 
in pain treatment for those suffering from pain related to AIDS and other conditions for 
which the therapeutic use of opioids is indicated. This may be particularly true in sub-
Saharan Africa where the number of patients with HIV-related pain is significant. However, 
even in Africa the burden of cancer is anticipated to overtake that of HIV, with cancer being 
the leading cause of death globally soon after 2020. The paucity of physicians in many 
countries including those of Africa makes access to opioids unlikely if prescribing is limited 
to physicians.”li 
 
3) Leverage the power of social networking to connect the global pain advocacy 
community.  In its “Relieving Pain in America” blueprint, the IOM recommended that 
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consumer advocates and organizations “Research evidence-based public health strategies 
directed at consumers that can be applied to the goal of reducing barriers to pain care.” lii 
Executed thoughtfully, the use of mass media (television, print), small media (brochures, 
posters) and social media (Facebook, Twitter) are all public health strategies that are 
endorsed by the U.S. Centers for Disease Control and Prevention’s “Community Guide” as 
an evidence-based and recommended best practice.
liii
   
 
While several organizations described above have made efforts to provide information that 
can be useful for consumer pain advocates, there is no one, single, global pain advocacy 
information exchange or social network.  Currently, information exchange is either one 
directional (organization to constituent, often health care professional), or, as in the case of 
World Hospice & Palliative Care Day, bi-directional (organization to/from constituent).  This 
research has identified an unmet need for a multi-directional information exchange where 
primarily consumer pain advocates can share their experiences, key learnings, and 
information about how they measured levels of success with their campaigns.  As the PPSG 
regional workshops have demonstrated, there is no global blueprint for pain care advocacy 
efforts.  However, this type of informal and interpersonal information exchange can provide 
a source of information, inspiration and support to consumer pain advocates as they find their 
voice.  Country-specific consumer pain organizations can also make materials available for 
local translation and cultural adaptation. This would be framed as an idea exchange as 
opposed to a road map; visitors would be able to view case studies, ask questions, comment, 
etc., but would ultimately be responsible for determining if these consumer advocacy efforts 
have local or regional applications based on current levels of accessibility to pain care.   
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There are, quite literally, billions of people around the world who are engaged on social 
networking sites such as Facebook (800+ million), Tencent QQ (674 million), Qzone  (480 
million), Netease (360 million) and Windows Live Messenger (330+ million), to name a 
few.
liv
  In the last several years, the use of social media and networking tools to share health 
messages has grown significantly, and continues to trend upward. Using social media tools 
has become an effective way to expand reach, foster engagement and increase access to 
credible, science-based health messages.  Social media and other emerging communication 
technologies can connect millions of voices to facilitate interactive communication, 
connection and public engagement.
lv
  
 
Sample implementation could include the use of buttons and badges to share a call to action 
about right to effective pain care, content syndication of materials, RSS feeds, featured 
podcasts and blogs from members.  The creation of the documentary shorts of LIFE Before 
Death and UBC PAIN Project are natural and current subjects for video sharing to inspire 
consumer advocacy efforts.  Lastly, social networking can be started through a simple 
Facebook page, or be more controlled through a more resource-intense and costly closed 
system, which would offer the advantage of being adjunct to a consumer’s social network of 
choice. 
 
Sustainability 
Sustainability, of course, is an important consideration, however not all of the recommendations 
stated above need to be costly. Major global funders with a passion for improving access to pain 
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care include the Open Society Foundation’s (OSF) International Palliative Care Initiative, the 
Mayday Fund, LIVESTRONG and the Lien Foundation.  International aid organizations such as 
the President’s Emergency Plan for AIDS Relief (PEPFAR), and the Global Fund to Fight AIDS, 
Malaria and Tuberculosis have been encouraged by Human Rights Watch to support palliative 
care efforts.  The OSF 2010 report “Easing the Pain: Successes and Challenges in International 
Palliative Care” includes a discussion of donor funding.  A consideration would be housing this 
exchange within a consumer organization who serves people with pain as this type of 
international collaboration among local pain advocacy organizations is not apparent.  It could 
also be a stand-alone entity. 
 
Conclusion  
People with acute or chronic pain often are unaware of their treatment options or may hold 
inaccurate or value-laden beliefs about pain that obstruct the path to treatment and relief.  They 
deserve information that can help them understand and address their condition.
lvi
  Approaching 
access to pain care from a human rights perspective has been an effective strategy in helping to 
frame this public health problem in a way that crystalizes the idea that pain treatment should not 
be withheld.  This skillfully laid groundwork needs to be taken further by raising awareness 
among people with pain to know their rights and speak up in defense of them.  This can and 
should involve the very people suffering.  Their stories are real and they matter; their efforts can 
and do make a difference. 
 
Patients are the ones who will 
actually make a change – Kathy 
Kreiter, Executive Director, IASP
1 
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There must be a critical mass that involves not just the tireless work of health care professionals 
and leaders who have devoted their lives and careers to this cause, but also caregivers, people 
with pain and “champions” as described so eloquently by the Open Societies Foundation:lvii   
…palliative care does not happen without those few extraordinarily impassioned, 
disciplined, talented, indefatigable people: the champions. So intrinsic to the process are 
champions that the International Palliative Care Initiative and the Pain & Policy Studies 
Group count them as among three necessary criteria for investing in their policy reform, 
along with a committed government and a regulatory structure that can be changed. 
 
The champions may come to palliative care from frustrating professional experiences, 
such as watching patients die in great pain. They may come to it—as so many people in 
the developing world do—having sat by the bedsides of their own family members and 
friends, as they suffered and died of AIDS or cancer. But what distinguishes the 
champions from the others who have witnessed the same tragedies is their extraordinary 
desire to do something about it, their charisma, their ability to get things done in the face 
of enormous challenges, and their refusal to give up. 
 
Current pain advocacy efforts are making a difference and have paved the way for consumer 
advocacy involvement.  This research has uncovered a number of exciting activities underway 
with the goal of improving pain care.  PPSG is expanding their report card analysis to create a 
tool to better evaluate and compare pain policies around the world, with support from 
LIVESTRONG.  Awareness efforts have also made gains.  World Hospice & Palliative Care Day 
has grown from 226 events in 60 countries in 2006, to more than 1,000 events in approximately 
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80 countries, just five years later in 2011.
lviii
  The LIFE Before Death documentary series is 
continuing its global rollout.  To maximize the impact of these advocacy opportunities and 
others, they should not be conducted at, or for, people with pain and their loved ones, but 
alongside them. 
  
 
“We need to be such a nuisance that officials say, 
‘…it’s easier to do what they’re asking us to do, 
than to have to keep up with them knocking on 
our doors…if we applied ourselves, this could be 
addressed in a few years.” 
 
– Diederik Lohman, Human Rights Watch, UBC 
PAIN Project
1
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Appendix: Organizations, Efforts and Projects Working toward Improved Access to 
Global Pain Care 
 
Access to Controlled Medicines Programme (ACME) 
http://www.who.int/medicines/areas/quality_safety/access_Contr_Med/en/index.html 
 
The Access to Opioid Medication in Europe (ATOME) project  
http://www.atome-project.eu/index.php 
 
Drug Control & Access to Medicine Consortium 
http://www.dcamconsortium.net/ 
 
Human Rights Watch 
www.hrw.org  
 
International Association for the Study of Pain (Includes contact information for country and 
regional professional pain societies)  
www.iasp-pain.org  
 
International Hospice & Palliative Care Organization 
www.hospicecare.com/ 
 
Open Society Foundation/International Palliative Care Initiative 
http://www.soros.org/initiatives/health/focus/ipci/events/cancer_20090824 
 
OSF: “Stop the Torture” Activism Campaign 
http://www.stoptortureinhealthcare.org/about-denial-of-pain-relief 
 
Pain & Policy Studies Group 
http://www.painpolicy.wisc.edu/ 
 
Lien Foundation (LIFE Before Death documentary) 
http://www.lienfoundation.org/specialproj.html 
 
LIVESTRONG  
www.livestrong.org 
 
Worldwide Palliative Care Alliance (Includes contact information for regional alliances, such as 
the African Palliative Care Alliance) 
http://www.thewpca.org/ 
 
World Hospice & Palliative Care Day 
http://www.worldday.org/ 
 
Union for International Cancer Control (UICC)/Global Access to Pain Relief Initiative (GAPRI)  
http://www.treatthepain.com/treat-the-pain-about-us 
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